Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical DEHP: still not enough studies, says cautious EC

This article was originally published in Clinica

Executive Summary

Certain medical procedures used in high-risk patients result in a significant exposure to di-(2-ethylhexyl) phthalate (DEHP), and, in view of the reproductive toxicity observed in animal studies, in which young, immature animals were more susceptible to DEHP toxicity, exposure from medical devices remains of special concern in relation to newborn and pre-term born male infants.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046601

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel